LI
XENT

Leap Investments’s Intersect ENT, Inc XENT Stock Holding History

Leap Investments’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-17,400
Closed -$296K – 650
2019
Q3 		$296K Sell
17,400
-6,300
-27% -$115K 0.15% 230
2019
Q2 		$539K Buy
+23,700
New +$639K 0.73% 35

Other funds holding XENT

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Leap Investments's XENT Position: Q4 2019 in Review

Leap Investments sold out of Intersect ENT, Inc (XENT) in Q4 2019, closing a stake of 17,400 shares — an estimated $296K sold.

Leap Investments first reported a position in XENT in Q2 2019 and held it in 2 quarters. The position peaked at $539K in Q2 2019. 120 funds tracked by Wall St. Rank hold XENT as of Q4 2019.

  • Leap Investments reported no remaining Intersect ENT, Inc position as of Q4 2019 after selling out during the quarter.
  • Leap Investments sold 17,400 Intersect ENT, Inc shares in Q4 2019, an estimated $296K.
  • Leap Investments first reported a position in Intersect ENT, Inc in Q2 2019 and held it in 2 quarters.
  • Leap Investments's Intersect ENT, Inc position peaked at $539K in Q2 2019.
  • 120 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q4 2019.

Based on Leap Investments's 13F filing for Q4 2019, filed 14 Feb 2020.